1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. 2015; Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. DOI:
10.1002/ijc.29210. PMID:
25220842.
3. Henley SJ, Weir HK, Jim MA, Watson M, Richardson LC. 2015; Gallbladder cancer incidence and mortality, United States 1999-2011. Cancer Epidemiol Biomarkers Prev. 24:1319–1326. DOI:
10.1158/1055-9965.EPI-15-0199. PMID:
26070529.
4. Wi Y, Woo H, Won YJ, Jang JY, Shin A. 2018; Trends in gallbladder cancer incidence and survival in Korea. Cancer Res Treat. 50:1444–1451. DOI:
10.4143/crt.2017.279. PMID:
29370591. PMCID:
PMC6192934.
5. Koea J, Phillips A, Lawes C, Rodgers M, Windsor J, McCall J. 2002; Gall bladder cancer, extrahepatic bile duct cancer and ampullary carcinoma in New Zealand: demographics, pathology and survival. ANZ J Surg. 72:857–861. DOI:
10.1046/j.1445-2197.2002.02589.x. PMID:
12485219.
6. Flemming JA, Zhang-Salomons J, Nanji S, Booth CM. Increased incidence but improved median overall survival for biliary tract cancers diagnosed in Ontario from 1994 through 2012: a population-based study. Cancer. 2016; 122:2534–2543. DOI:
10.1002/cncr.30074. PMID:
27183133.
8. Torre LA, Siegel RL, Islami F, Bray F, Jemal A. 2018; Worldwide burden of and trends in mortality from gallbladder and other biliary tract cancers. Clin Gastroenterol Hepatol. 16:427–437. DOI:
10.1016/j.cgh.2017.08.017. PMID:
28826679.
11. Kim HJ, Fay MP, Feuer EJ, Midthune DN. 2000; Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 19:335–351. Erratum in: Stat Med 2001;20:655. DOI:
10.1002/sim.811. PMID:
10649300.
16. Serra I, Yamamoto M, Calvo A, Cavada G, Báez S, Endoh K, Watanabe H, Tajima K. 2002; Association of chili pepper consumption, low socioeconomic status and longstanding gallstones with gallbladder cancer in a Chilean population. Int J Cancer. 102:407–411. Erratum in: Int J Cancer 2003;104:798. DOI:
10.1002/ijc.10716. PMID:
12402311.
17. Lee MH, Gao YT, Huang YH, McGee EE, Lam T, Wang B, et al. 2020; A metallomic approach to assess associations of serum metal levels with gallstones and gallbladder cancer. Hepatology. 71:917–928. DOI:
10.1002/hep.30861. PMID:
31318976. PMCID:
PMC6980252.
18. Randi G, Franceschi S, La Vecchia C. 2006; Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer. 118:1591–1602. DOI:
10.1002/ijc.21683. PMID:
16397865.
19. Dutta U, Bush N, Kalsi D, Popli P, Kapoor VK. 2019; Epidemiology of gallbladder cancer in India. Chin Clin Oncol. 8:33. DOI:
10.21037/cco.2019.08.03. PMID:
31484488.
21. Lowenfels AB, Walker AM, Althaus DP, Townsend G, Domellöf L. 1989; Gallstone growth, size, and risk of gallbladder cancer: an interracial study. Int J Epidemiol. 18:50–54. DOI:
10.1093/ije/18.1.50. PMID:
2722383.
24. Zhang X, Condon J, Dempsey K, Garling L. Cancer in the Northern Territory 1991-2010: incidence, mortality and survival. Darwin: Department of Health;2014. DOI:
10.1093/ije/18.1.50.
25. Wigg AJ, Narayana SK, Hartel G, Medlin L, Pratt G, Powell EE, et al. 2021; Hepatocellular carcinoma amongst Aboriginal and Torres Strait Islander peoples of Australia. EClinicalMedicine. 36:100919. DOI:
10.1016/j.eclinm.2021.100919. PMID:
34142069. PMCID:
PMC8187829.
26. Kamiza AB, Su FH, Wang WC, Sung FC, Chang SN, Yeh CC. 2016; Chronic hepatitis infection is associated with extrahepatic cancer development: a nationwide population-based study in Taiwan. BMC Cancer. 16:861. DOI:
10.1186/s12885-016-2918-5. PMID:
27821099. PMCID:
PMC5100218.
27. Hsing AW, Zhang M, Rashid A, McGlynn KA, Wang BS, Niwa S, et al. 2008; Hepatitis B and C virus infection and the risk of biliary tract cancer: a population-based study in China. Int J Cancer. 122:1849–1853. DOI:
10.1002/ijc.23251. PMID:
18076042.
28. DiGiacomo M, Davidson PM, McGrath SJ, Dharmendra T, Thompson SC. 2012. Cancer in aboriginal and torres strait islander peoples: a rapid review of the literature. Sydney: UTS ePress;DOI:
10.1002/ijc.23251.
29. Wietsma MFT, Molloy C, Bhimani N, de Savornin Lohman EAJ, Gill AJ, Andrici J, et al. 2021; Gallbladder carcinoma outcomes in an Australian tertiary referral hospital. ANZ J Surg. 91:603–608. DOI:
10.1111/ans.16663. PMID:
33604992.
30. Cocker F, Chien Yee K, Palmer AJ, de Graaff B. 2019; Increasing incidence and mortality related to liver cancer in Australia: time to turn the tide. Aust N Z J Public Health. 43:267–273. DOI:
10.1111/1753-6405.12889. PMID:
30958629.
31. Wallace MC, Preen DB, Short MW, Adams LA, Jeffrey GP. Hepatocellular carcinoma in Australia 1982-2014: increasing incidence and improving survival. Liver Int. 2019; 39:522–530. DOI:
10.1111/liv.13966. PMID:
30230194.
32. Young JP, Win AK, Rosty C, Flight I, Roder D, Young GP, et al. 2015; Rising incidence of early-onset colorectal cancer in Australia over two decades: report and review. J Gastroenterol Hepatol. 30:6–13. DOI:
10.1111/jgh.12792. PMID:
25251195.
33. Mikaeel RR, Young JP, Hardingham JE, Tapia Rico G, Hewett PJ, Symonds EL, et al. 2021; Appendiceal neoplasm incidence and mortality rates are on the rise in Australia. Expert Rev Gastroenterol Hepatol. 15:203–210. DOI:
10.1080/17474124.2021.1832467. PMID:
33022181.